Reindeer Biotech in Nanjing’s Jiangbei New Area is behind development of the world’s first fully human CAR-T product targeting BCMA (B cell maturation antigen). Full story (in Chinese) via this link.
![The Nanjinger - Cancer Treatment Gets World First from Firm in Nanjing The Nanjinger - Cancer Treatment Gets World First from Firm in Nanjing](https://i0.wp.com/www.thenanjinger.com/wp-content/uploads/2023/08/The-Nanjinger-Cancer-Treatment-Gets-World-First-from-Firm-in-Nanjing.jpg?resize=696%2C417&ssl=1)
Reindeer Biotech in Nanjing’s Jiangbei New Area is behind development of the world’s first fully human CAR-T product targeting BCMA (B cell maturation antigen). Full story (in Chinese) via this link.